Quantcast

Latest Sanofi Stories

2014-03-18 08:29:03

For MS Awareness Month, MSAA Launches Effort to Get More People with MS in the Pool CHERRY HILL, N.J., March 18, 2014 /PRNewswire/ -- In honor of Multiple Sclerosis (MS) Awareness Month, the Multiple Sclerosis Association of America (MSAA), through a collaborative partnership with Genzyme, a Sanofi company, is proud to announce the stories from three individuals in the MS community who describe how swimming has helped manage their MS symptoms and improve their overall well-being. Today, MSAA...

2014-03-14 23:24:36

Nationwide truck wraps manufacturer JMR Graphics comments on an article discussing Selsun Blue’s new goofy, but realistic advertisement. Central Islip, NY (PRWEB) March 14, 2014 JMR Graphics, a nationwide truck wraps manufacturer, responds to an article discussing popular hair dandruff shampoo brand Selsun Blue and their use of snow for their new billboard advertisement in Montreal. According to a March 3rd article from AdWeek titled, “Endless Winter Isn't So Bad If You're...

2014-03-05 12:27:25

Minerva president Rogerio Vivaldi and board chairman Marc Beer leading strategy to advance pipeline of novel therapies targeting applications in neuropsychiatry. CAMBRIDGE, Mass., March 5, 2014 /PRNewswire/ -- Minerva Neurosciences, Inc., a leader in the development of new therapies to treat neuropsychiatric diseases and disorders, today announced the launch of the new company web site (www.minervaneurosciences.com) following the successful transfer of the Minerva Neurosciences corporate...

2014-03-03 00:21:43

LYON, France, March 3, 2014 /PRNewswire/ -- - Sanofi Pasteur works with global partners to make available unparalleled quantities of affordable Inactivated Polio Vaccine (IPV) - Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today its further commitment to the international community's efforts to complete polio eradication. UNICEF, the organization that procures the vaccine to meet global needs, announced...

2014-02-28 23:01:12

ChinaMarketResearchReports.com adds Latest Report on “Investigation Report on China Insulin Glargine Market, 2009-2018” to its store. Dallas, TX (PRWEB) March 01, 2014 Description With the improvement of people's living standard and changing of lifestyles, as well as deepening of the aging of society, prevalence rate of diabetes keeps rising, making it the third most threatening chronic disease to human health after tumor and cardiovascular disease. Its risk to disable or kill has...

2014-02-28 08:25:23

DUBLIN, Feb. 28, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Dronedarone Hydrochloride Tablets 400 mg. Actavis' ANDA product is a generic version of Sanofi's Multaq(®), which is an antiarrhythmic drug indicated to reduce the risk of hospitalization for atrial fibrillation (AF) in patients in sinus rhythm with a history of...

2014-02-19 08:31:31

Talks by Holopack and Sanofi will highlight innovative software solutions supporting environmental monitoring and externalized collaboration; Accelrys to address mobile initiatives in the lab SAN DIEGO, Feb. 19, 2014 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced that it is sponsoring four talks at the 9th Annual SmartLab Exchange to be held on February 25-26 in Munich. As Europe's premier...

2014-02-12 12:30:26

LONDON, Feb. 12, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Brazilian Pharmaceutical Market 2014-2024Report DetailsDrug selling in Brazil - this new analysis shows you trends, opportunities, and revenuesDo you want to assess the future of pharmaceuticals in Brazil? See what lies ahead, then. Visiongain's new report gives you revenue predictions, helping your work. There you discover financial results, trends, opportunities, and sales forecasts.So...

2014-02-11 08:30:49

- Fourth quarter 2013 EYLEA® (aflibercept) Injection global net sales were $586 million, consisting of $402 million in the U.S. and $184 million in rest of world(1) TARRYTOWN, N.Y., Feb. 11, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced financial results for the fourth quarter and full year 2013 and provided an update on development programs....

2014-02-06 08:27:40

PARIS, Feb. 6, 2014 /PRNewswire/ -- Sanofi (NYSE: SNY; EURONEXT: SAN) Q4 2013 Change (reported) Change (CER) 2013 Change (reported) Change (CER) Net sales EUR8,457m -0.8% +6.5% EUR32,951m -5.7% -0.5% Business net income(1) EUR1,810m...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related